Related Experiment Videos
Expression and clinical significance of miR-223 in children with severe pneumonia
Min Wang1,2, Juan Wang1,2, Mengmeng Chen1,2
1Clinical Laboratory, Children's Hospital Affiliated to Shandong University, 23976 Jing-Shi Road, Jinan, 250022, Shandong Province, PR China.
Insights
Plasma miR-223 is a promising biomarker for early detection of severe pneumonia in children. Combining miR-223 with routine markers significantly improves diagnostic accuracy and risk assessment for pediatric severe pneumonia.
Area of Science:
- Pediatric Pulmonology
- Molecular Diagnostics
- Biomarker Discovery
Background:
- Severe pneumonia is a leading cause of mortality in children under 5.
- Current diagnostic markers lack specificity for early identification and severity assessment.
- Novel biomarkers are crucial for timely and accurate diagnosis of pediatric severe pneumonia.
Purpose of the Study:
- To investigate the diagnostic value of plasma miR-223 in pediatric severe pneumonia.
- To evaluate the combined diagnostic performance of miR-223 with routine clinical indicators.
- To assess the correlation of miR-223 with disease severity and prognosis.
Main Methods:
- Quantitative real-time PCR for plasma miR-223 expression.
- Collection of routine hematological, biochemical, and coagulation markers.
- Statistical analyses including logistic regression and ROC curve analysis.
Main Results:
- Plasma miR-223 levels were significantly elevated in children with severe pneumonia.
- miR-223, neutrophil percentage, albumin, and fibrinogen were independent risk factors.
- Combined model achieved an AUC of 0.99, outperforming single markers.
- miR-223 upregulation was consistent across age subgroups.
Conclusions:
- Plasma miR-223 is a reliable biomarker for pediatric severe pneumonia.
- Combination with routine markers enhances diagnostic efficiency and risk evaluation.
- miR-223 aids in disease stratification and prognosis assessment for children with severe pneumonia.
Abstract:
Severe pneumonia poses a major life-threatening respiratory disease among children under 5 years old, and conventional laboratory markers lack sufficient specificity for its early identification and severity evaluation, highlighting an urgent need for novel sensitive and specific biomarkers. This study enrolled 107 children diagnosed with severe pneumonia and 107 age- and gender-matched healthy children from January 2024 to June 2025. Quantitative real-time PCR was applied to detect plasma miR-223 expression, and routine hematological, biochemical and coagulation indicators were simultaneously collected for all subjects. Statistical analyses including Mann-Whitney U test, multivariate logistic regression and ROC curve analysis were performed to explore the diagnostic value of miR-223. Plasma miR-223 expression was significantly elevated in children with severe pneumonia compared with healthy controls, and multivariate logistic regression identified miR-223, neutrophil percentage, albumin and fibrinogen as independent risk factors for pediatric severe pneumonia. Single miR-223 yielded an AUC of 0.90 for disease diagnosis, while the combined model of the four indicators achieved an AUC up to 0.99 with superior diagnostic accuracy and sensitivity. Age stratification analysis revealed that miR-223 upregulation existed across all age subgroups of patients, and age exerted no significant interference on its diagnostic performance. Moreover, higher miR-223 levels were correlated with severe complications, PICU admission and longer hospital stays, indicating its potential for disease stratification and short-term prognosis assessment. In summary, plasma miR-223 acts as a reliable molecular biomarker for pediatric severe pneumonia, and its combination with routine inflammatory, nutritional and coagulation markers greatly improves diagnostic efficiency, which provides a promising auxiliary tool for early diagnosis and clinical risk evaluation of children with severe pneumonia.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Respiratory Syncytial Virus Disease
Atypical Pneumonia